Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Thursday broker round-up UPDATE

Thu, 27th Jun 2013 07:36
Antofagasta: Investec cuts target price from 892p to 691p downgrading from reduce to sell.Black Mountain Resources: Westhouse Securities shifts target price from 23p to 17p, while its buy recommendation remains unaltered.Bunzl: Numis upgrades to buy with a target price of 1505p.Capita: Jefferies raises target price from 1010p to 1080p and keeps a buy recommendation.Carphone Warehouse Group: Exane moves target price from 280p to 290p and stays with its outperform rating. Deutsche Bank ups target price from 260p to 285p retaining a buy recommendation.Centrica: JP Morgan takes target price from 370p to 390p and upgrades to overweight.Consort Medical: N+1 Singer raises target price from 855p to 870p maintaining a buy recommendation.Direct Line: Nomura increases target price from 203p to 242p, while maintaining a neutral rating. Deutsche Bank moves target price from 210p to 230p and stays with its hold recommendation. RBC Capital Markets ups target price from 240p to 260p and keeps an outperform rating.Enables IT: Sanlam Securities in initiates with a target price of 65p and a buy recommendation.Judges Scientific: WH Ireland moves target price from 1400p to 1450p and reiterates a buy recommendation.Land Securities: Morgan Stanley ups target price from 900p to 940p retaining an overweight rating.Safestore: Investec raises target price from 125p to 140p maintaining a buy recommendation.Sepura: Westhouse Securities initiates with a target price of 135p and an add recommendation.Stagecoach Group: Deutsche Bank takes target price from 310p to 330p and reiterates its buy recommendation.Standard Chartered: JP Morgan reduces target price from 1920p to 1800p keeping a neutral rating.SuperGroup: Cantor Fitzgerald raises target price from 820p to 900p leaving its buy recommendation unchanged.Tate & Lyle: Morgan Stanley initiates with a target price of 975p and an overweight rating.Unilever: Panmure Gordon cuts target price from 3000p to 2900p, while leaving its buy recommendation unchanged.

Related News

Haleon among bidders for supplements maker Thorne, sources say
1 day ago

Haleon among bidders for supplements maker Thorne, sources say

* Thorne attracted strategic interest, including ​a ⁠bid from Haleon, sources say

WINNERS & LOSERS: British American Tobacco announces buyback
1 day ago

WINNERS & LOSERS: British American Tobacco announces buyback

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.

LONDON BROKER RATINGS: Berenberg cuts Berkeley and raises Bellway
1 day ago

LONDON BROKER RATINGS: Berenberg cuts Berkeley and raises Bellway

(Alliance News) - The following London-listed shares received analyst recommendations on Friday morning and on Thursday:

CSRT.L News

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
17 Feb 2020

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Monday broker round-up
10 Feb 2020

Monday broker round-up

(Sharecast News) - Consort Medical: RBC Capital Markets upgrades to sector performer with a target price of 1,010p.

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional
4 Feb 2020

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm To Make No Further Changes To Consort Medical Offer
29 Jan 2020

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm Extends Consort Medical Offer Deadline To February 4
24 Jan 2020

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Buys 10% Of Takeover Target Consort Medical
22 Jan 2020

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle
14 Jan 2020

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Friday broker round-up
10 Jan 2020

Friday broker round-up

(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.